Cargando…

Targeting ALK in Cancer: Therapeutic Potential of Proapoptotic Peptides

ALK is a receptor tyrosine kinase, associated with many tumor types as diverse as anaplastic large cell lymphomas, inflammatory myofibroblastic tumors, breast and renal cell carcinomas, non-small cell lung cancer, neuroblastomas, and more. This makes ALK an attractive target for cancer therapy. Sinc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aubry, Arthur, Galiacy, Stéphane, Allouche, Michèle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468335/ https://www.ncbi.nlm.nih.gov/pubmed/30813562 http://dx.doi.org/10.3390/cancers11030275

Ejemplares similares

Peptides derived from the dependence receptor ALK are proapoptotic for ALK-positive tumors
por: Aubry, A, et al.
Publicado: (2015)

Potential proapoptotic phytochemical agents for the treatment and prevention of colorectal cancer
por: Ahmed, Kanwal, et al.
Publicado: (2019)

Proapoptotic Cyclic Peptide BC71 Targets Cell-Surface GRP78 and Functions as an Anticancer Therapeutic in Mice
por: Kao, Chieh, et al.
Publicado: (2018)

Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis
por: Su, Fei, et al.
Publicado: (2020)

Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
por: Yuan, Yuan, et al.
Publicado: (2011)

ALK and NSCLC: Targeted therapy with ALK inhibitors
por: Hallberg, Bengt, et al.
Publicado: (2011)

Therapeutic Sequencing in ALK(+) NSCLC
por: Elsayed, Mei, et al.
Publicado: (2021)

Targeting Autophagy in ALK-Associated Cancers
por: Frentzel, Julie, et al.
Publicado: (2017)

CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma
por: An, Rong, et al.
Publicado: (2016)

Proapoptotic role of nuclear clusterin in brain
por: Kim, Nayoung, et al.
Publicado: (2011)

The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma
por: Feng, Songshan, et al.
Publicado: (2022)

In vivo metal-catalyzed SeCT therapy by a proapoptotic peptide
por: Ahmadi, Peni, et al.
Publicado: (2021)

NPM-ALK: A Driver of Lymphoma Pathogenesis and a Therapeutic Target
por: Andraos, Elissa, et al.
Publicado: (2021)

ALK in Neuroblastoma: Biological and Therapeutic Implications
por: Trigg, Ricky M., et al.
Publicado: (2018)

Generating the Abscopal Effect by Combining Proapoptotic Peptides With IL-12-Based Immunotherapy()
por: Martins, Filipe, et al.
Publicado: (2017)

Therapeutic Targeting of the Anaplastic Lymphoma Kinase (ALK) in Neuroblastoma—A Comprehensive Update
por: Brenner, Annette K., et al.
Publicado: (2021)

Proapoptotic effect of endocannabinoids in prostate cancer cells
por: ORELLANA-SERRADELL, O., et al.
Publicado: (2015)

Site-Dependent Cysteine Lipidation Potentiates the Activation of Proapoptotic BAX
por: Cohen, Daniel T., et al.
Publicado: (2020)

Cytotoxic and Proapoptotic Effects of Resveratrol in In Vitro Studies on Selected Types of Gastrointestinal Cancers
por: Ratajczak, Katarzyna, et al.
Publicado: (2021)

The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
por: Golding, Brandon, et al.
Publicado: (2018)

ALK: a tyrosine kinase target for cancer therapy
por: Holla, Vijaykumar R., et al.
Publicado: (2017)

ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers
por: Wellstein, Anton
Publicado: (2012)

Lumican Peptides: Rational Design Targeting ALK5/TGFBRI
por: Gesteira, Tarsis Ferreira, et al.
Publicado: (2017)

Wasp venom peptide improves the proapoptotic activity of alendronate sodium in A549 lung cancer cells
por: Alhakamy, Nabil A., et al.
Publicado: (2022)

Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis
por: D’Alessandro-Gabazza, Corina N., et al.
Publicado: (2022)

Effect of Trimethine Cyanine Dye- and Folate-Conjugation on the In Vitro Biological Activity of Proapoptotic Peptides
por: Cardella, Davide, et al.
Publicado: (2022)

Corneal epithelium in keratoconus underexpresses active NRF2 and a subset of oxidative stress-related genes
por: Lupasco, Tatiana, et al.
Publicado: (2022)

AKT1-targeted proapoptotic activity of compound K in human breast cancer cells
por: Choi, Eunju, et al.
Publicado: (2019)

Selective Anticancer Properties, Proapoptotic and Antibacterial Potential of Three Asplenium Species
por: Petkov, Venelin, et al.
Publicado: (2021)

Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK Inhibitors
por: Poddubskaya, Elena, et al.
Publicado: (2019)

New Steroidal Selenides as Proapoptotic Factors
por: Jastrzebska, Izabella, et al.
Publicado: (2023)

The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung Cancer
por: Gristina, Valerio, et al.
Publicado: (2020)

Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer
por: Xiang, Yan, et al.
Publicado: (2022)

Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors
por: Chia, Puey Ling, et al.
Publicado: (2014)

Activating mutations in ALK provide a therapeutic target in neuroblastoma
por: George, Rani E., et al.
Publicado: (2008)

Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma
por: Cazes, Alex, et al.
Publicado: (2014)

Therapeutic effect of daphnetin on the autoimmune arthritis through demethylation of proapoptotic genes in synovial cells
por: Shu, Kuanyong, et al.
Publicado: (2014)

Ultrastructural and proapoptotic-like effects of kaempferol in Giardia duodenalis trophozoites and bioinformatics prediction of its potential protein target
por: Argüello-García, Raúl, et al.
Publicado: (2020)

Targeting MYCN and ALK in resistant and relapsing neuroblastoma
por: Tucker, Elizabeth R, et al.
Publicado: (2019)

Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review
por: Iannantuono, Giovanni Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qj9o92g1ag63jv57ae0pf5vu5b